AcelRx Pharmaceuticals
ACRX
$0.67
Share price
-9.73%
Change (1 day)
-84.76%
Change (1 year)
Categories
Revenue for AcelRx Pharmaceuticals (ACRX)
Revenue in 2023 (TTM): $1.01 M
According to AcelRx Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $1.01 M. In 2022 the company made a revenue of $1.77 M a decrease over the years 2021 revenue that were of $2.81 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for AcelRx Pharmaceuticals from 2010 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $1.01 M | -42.86% |
| 2022 | $1.77 M | -37.15% |
| 2021 | $2.81 M | -47.97% |
| 2020 | $5.41 M | 136.61% |
| 2019 | $2.28 M | 6.42% |
| 2018 | $2.15 M | -73.1% |
| 2017 | $7.99 M | -53.94% |
| 2016 | $17.35 M | -9.89% |
| 2015 | $19.26 M | 269.24% |
| 2014 | $5.21 M | -82.32% |
| 2013 | $29.5 M | 1132.33% |
| 2012 | $2.39 M | 123.32% |
| 2011 | $1.07 M | |
| 2010 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Recro Pharma
REPH | $75.36 M | 7,346.64% | 🇺🇸 USA |
 Cara Therapeutics
CARA | $27.17 M | 2,584.98% | 🇺🇸 USA |